Inhibition of p38 MAP Kinase Activity Up-Regulates Multiple MAP Kinase Pathways and Potentiates 1,25-Dihydroxyvitamin D3-Induced Differentiation of Human Leukemia HL60 Cells
- 1 August 2000
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 258 (2) , 425-437
- https://doi.org/10.1006/excr.2000.4939
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1Published by Wiley ,2000
- Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3–dependent signal transduction by phosphorylating human retinoid X receptor αJournal of Clinical Investigation, 1999
- 1,25-Dihydroxyvitamin D3Induced Activation and Subsequent Nuclear Translocation of MAPK Is Upstream Regulated by PKC in HL-60 CellsBiochemical and Biophysical Research Communications, 1997
- Cloning and Characterization of MEK6, a Novel Member of the Mitogen-activated Protein Kinase Kinase CascadePublished by Elsevier ,1996
- Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleusCurrent Biology, 1995
- Resolution of multiple AP-1 complexes in HL-60 cells induced to differentiate by 1,25-dihydroxyvitamin D3Journal of Cellular Physiology, 1993
- The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domainCell, 1993
- Phosphorylation of c-jun mediated by MAP kinasesNature, 1991
- 1α,25-Dihyroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytesBiochemical and Biophysical Research Communications, 1983
- Expression of myeloid differentiation antigens on normal and malignant myeloid cells.Journal of Clinical Investigation, 1981